Brand: Cipla
Availability: In Stock
Price: USD $36.00
* Packages:

Rating : 1 reviews

Suhagra 25 mg is a mild tablet with a major principal ingredient of Sildenafil Citrate. It helps in gaining a hard erection of penile for a longer duration to enjoy complete satisfactory sexual intercourse with your partner. The doctor may prescribe you with this medicine as an initial dose for the said symptoms of ED or impotence. Cipla Pvt Ltd has manufactured this medicine.

Active Ingredient:
The principal component present in this medicine is Sildenafil Citrate which boosts up the blood flow in the penile region maintaining a firm erection for longer sexual activity. The active ingredient in this medicine will help you get a long-lasting erection that may last up to 4 hours.

The active ingredient in this medicine treats impotency in many ways and helps you achieve a stiffer penile erection for long-lasting sexual intercourse. The lowest dose available in the market is Suhagra 25 mg which turns out to be very effective in treating erectile dysfunction or impotence in men. To achieve a penile erection and sustain the construction throughout the sexual intercourse this medicine works as the best medicinal solution.

 It is always advisable to follow your doctor’s prescriptions and instructions before consuming this medicine. Most importantly, Suhagra 25 enhances the level of blood flow in the penile region to help men achieving a harder and stiffer penile.

Avoid having this medicine for more than one tablet a day as this can lead you to severe side effects. Make sure to consume this medicine, an hour before getting physically intimate with your partner

This medicine should not be used as a source to increase sexual desire as it only contributes to a sexual stimulation drug. Painful erection for a long time, sleeplessness, muscle aches, body ache, etc. can be some of the serious side effects of overconsumption.


Write a review

Your Name:

Your Review: Note: HTML is not translated!

Rating: Bad            Good

Enter the code in the box below:

Logos and trademarks remain the property of the corresponding companies. © 2021